https://scholars.lib.ntu.edu.tw/handle/123456789/537490
標題: | HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia | 作者: | SHANG-JU WU MING YAO JIH-LUH TANG BOR-SHENG KO HWEI-FANG TIEN YAO-CHANG CHEN |
公開日期: | 2009 | 出版社: | Scientific Communications International Ltd | 卷: | 108 | 期: | 5 | 起(迄)頁: | 423-427 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | The immunomodulating effect of human leukocyte antigen (HLA)-DR and the central role of CD4 T cells in alloimmunity provide clues suggesting that HLA-DR-matched, partially mismatched related donors could be feasible alternative donors of allogeneic hematopoietic stem cells for transplantations (alloHSCT). We describe our experience with allo-HSCT in eight patients with high-risk acute leukemia; donors included one of each of the parents. Among the eight patients, seven were identical HLA-DR matches with the donors. The stem cells were not manipulated in vitro. Graft-versus-host disease (GVHD) prophylaxis consisted of antithymocyte globulin, cyclosporine, and methotrexate. All patients had successful trilineage engraftment. Only one patient had grade 2-4 acute GVHD. Two patients died before day +100 due to complications. At the end of follow-up, four patients had survived for 18-48 months and three are alive and without relapse. Our results suggest that HLA-DR fully-matched parents are feasible alternative donors for allo-HSCT in patients with high-risk acute leukemia under an intensive conditioning regimen. ?2009 Elsevier & Formosan Medical Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649586909&doi=10.1016%2fS0929-6646%2809%2960087-5&partnerID=40&md5=813ff8f7a05fbf072cc4d365d1635272 https://scholars.lib.ntu.edu.tw/handle/123456789/537490 |
ISSN: | 0929-6646 | DOI: | 10.1016/S0929-6646(09)60087-5 | SDG/關鍵字: | busulfan; cyclophosphamide; cyclosporin A; fludarabine; fludarabine phosphate; HLA DR antigen; methotrexate; recombinant granulocyte colony stimulating factor; thymocyte antibody; acute graft versus host disease; acute leukemia; adolescent; adult; allogeneic hematopoietic stem cell transplantation; article; Aspergillus; cancer survival; cell manipulation; chemoprophylaxis; chronic graft versus host disease; clinical article; cytomegalovirus infection; donor lymphocyte infusion; engraftment; father; feasibility study; female; graft versus host reaction; hematopoietic stem cell; high risk patient; HLA matching; human; immunosuppressive treatment; leukemia relapse; leukemia remission; living donor; lung mycosis; male; mortality; mother; neutropenia; parent; pilot study; virus pneumonia; virus reactivation; whole body radiation |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。